Nanoparticle‐based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines-Reference-Cited by-同舟云学术

Nanoparticle‐based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines

Published:2021-05-04 Issue:5 Volume:13 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Zhou Peijie¹^ORCID,Liu Wei¹,Cheng Yong¹,Qian Dong¹^ORCID

Affiliation:

1. Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China

Funder

Natural Science Foundation of Anhui Province

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1718

Reference103 articles.

1. Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial

2. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade–specific epigenome and transcriptome landscapes

3. HPV: Molecular pathways and targets

4. Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer

5. Targeted Agents in Cervical Cancer: Beyond Bevacizumab

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer;EJNMMI Radiopharmacy and Chemistry;2024-08-24

2. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

3. Navigating the novel nanoparticles: current insights, innovations, and future vistas in detection and treatment of cervical cancer;Nanocomposites;2024-06

4. Current development of theragnostic nanoparticles for women’s cancer treatment;Biomedical Materials;2024-05-08

5. Nano-based vaccination and their administration routes in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024